SOX9 Is a Novel Cancer Stem Cell Marker Surrogated by Osteopontin in Human Hepatocellular Carcinoma

Scientific Reports - United Kingdom
doi 10.1038/srep30489
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aldehyde Dehydrogenase Activity Is a Cancer Stem Cell Marker of Tongue Squamous Cell Carcinoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2012English

An Osteopontin Fragment Is Essential for Tumor Cell Invasion in Hepatocellular Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

SAC3D1: A Novel Prognostic Marker in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

Lrig1 Is a Positive Prognostic Marker in Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2016English

Epigenetic Regulation of Pluripotent Genes Mediates Stem Cell Features in Human Hepatocellular Carcinoma and Cancer Cell Lines

PLoS ONE
Multidisciplinary
2013English

Plasma Osteopontin as a Novel Diagnostic Biomarker for Early Detection of Hepatocellular Carcinoma.

International Journal of Advanced Research
2017English

Highly Tumorigenic Hepatocellular Carcinoma Cell Line With Cancer Stem Cell-Like Properties

PLoS ONE
Multidisciplinary
2017English

Novel Endothelial Cell Markers in Hepatocellular Carcinoma

Modern Pathology
Forensic MedicinePathology
2004English

Defeating EpCAM+ Liver Cancer Stem Cells by Targeting Chromatin Remodeling Enzyme CHD4 in Human Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy